Ishita Drugs And Industries Limited
Ishita Drugs And Industries Limited is a Public Non-govt company company incorporated in 1992 and based in Gujarat, India. Ishita Drugs And Industries Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹3.50 Cr and paid-up capital of ₹2.99 Cr. For 2019-20, the company reported revenue of ₹14.83 Cr and profit after tax of ₹54.71 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
ISHITA DRUGS AND INDUSTRIES LIMITED is the legal entity of Ishita Drugs & Industries.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Ishita Drugs And Industries Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +21d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Ishita Drugs And Industries Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 613207177 | Axis Bank Ltd(Bank) | ₹13.43 Cr | 19 Sep 2019 | Open |
| 222180654 | HDFC Bank Ltd(Bank) | ₹4.90 Cr | 04 Jul 2019 | Satisfied |
| 105671327 | Kotak Mahindra Bank Ltd(Bank) | ₹57.04 L | 12 Mar 2020 | Satisfied |
| 291955288 | ICICI Bank Ltd(Bank) | ₹5.37 Cr | 12 Mar 2020 | Open |
| 968714641 | Kotak Mahindra Bank Ltd(Bank) | ₹11.11 Cr | 19 Sep 2021 | Open |
Charge IDs, lenders & amounts for Ishita Drugs And Industries Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2019-20 | — |
Detailed Financials
1 FYs| Line item | 2019-20 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹76.42 Cr | -3.2% | +4.1% | +19.1% |
| Profit after Tax | ₹3.34 Cr | +20.9% | +9.9% | -2.7% |
| Net Worth | ₹51.43 Cr | +11.8% | +3.7% | +7.1% |
| Employees | 387 | +24.7% | +8.2% | +16.4% |
Audited financials & ratios for Ishita Drugs And Industries Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | +3.69% | — | +7.86% | +5.82% | 0.35 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,07,32,230 | 57.79% |
| Institutional Investors | 2 | 46,86,450 | 13.06% |
| Public & Others | 28 | 1,04,58,330 | 29.15% |
Promoter, institutional & public holding for Ishita Drugs And Industries Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
32 peersTop 5 in Chemical substances used in the manufacture of anti-biotic, manufacturing
by healthView all ›Events & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.